Bolt Biotherapeutics (BOLT)
(Delayed Data from NSDQ)
$0.69 USD
0.00 (-0.71%)
Updated Aug 28, 2024 04:00 PM ET
After-Market: $0.68 -0.01 (-0.73%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.43 | 28.32% |
Earnings Summary
For their last quarter, Bolt Biotherapeutics (BOLT) reported earnings of -$0.56 per share, missing the Zacks Consensus Estimate of -$0.54 per share. This reflects a negative earnings surprise of 3.70%. Look out for BOLT's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.43 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for BOLT
Dianthus Therapeutics, Inc. (DNTH) Reports Q2 Loss, Tops Revenue Estimates
BOLT: What are Zacks experts saying now?
Zacks Private Portfolio Services